Incidence of major complication following embolo-sclerotherapy for upper and lower extremity vascular malformations.

CONCLUSIONS: Embolo-sclerotherapy is relatively safe for upper and lower extremity vascular malformations in a high-volume experienced center where our major complication rates were 14.3% and 4.7%, respectively, which compare favorably or similar to those reported in most recent literature. These outcomes will direct treatment strategies to avoid local and systemic toxic complications in the upper and lower extremity, for both HFVM and LFVM, and to improve informed consent. PMID: 32605532 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32605532?dopt=Abstract

Source: Vascular - June 30, 2020 Category: Surgery Authors: Lim CS, Evans N, Kaur I, Papadopoulou A, Khalifa M, Tsui J, Hamilton G, Brookes J Tags: Vascular Source Type: research